Please assess the completion status of the following clinical trial:

Trial Title: Intravenous Ascorbic Acid Administration in Hysterectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* To be 18 years and older~* No smoking~* No history of bleeding disorder~* No history of favism~* No history of uterus, ovary, cervical cancer~Exclusion Criteria:~* Need to injection of vasopressor drugs~* Surgeon disagreement

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- vitamin C (Type: EXPERIMENTAL): Intervention patients will be received double dose of Ascorbic acid via intravenous injection
- Control (Type: NO_INTERVENTION): Control patients will not be received any intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).